Evidence map›Paper›PMID 25246494›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa.

Geetha H Mylvaganam, Vijayakumar Velu, Jung-Joo Hong, Shanmugalakshmi Sadagopal, Suefen Kwa, Rahul Basu, Benton Lawson, Francois Villinger, Rama Rao Amara

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 46 citations in OpenAlex.

  1. An angel or a devil? Current view on the role of CD8Journal of translational medicine · 2024
    Review
  2. Cytolytic CD8Science immunology · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Strong TScience translational medicine · 2019
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Geetha H MylvaganamDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and.
Vijayakumar VeluDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and.
Jung-Joo HongEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322.
Shanmugalakshmi SadagopalDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and.
Suefen KwaDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and.
Rahul BasuDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and.
Benton LawsonEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and.
Francois VillingerEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322.
Rama Rao AmaraDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and ramara@emory.edu.
Emory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Role of Follicular T Helper Cells In Enhancing Humoral Immunity and ProtectionU19AI096187 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO, HUNTER, ERIC · 2011 to 2015
$26.5M
Targeting mTOR to Enhance Immunogenicity and Efficacy of HIV VaccinesP01AI088575 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2010 to 2013
$11.4M
Targeting PD-1 Pathway for Functional Cure of AIDSR37AI112787 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2014 to 2023
$9.2M
Therapeutic DNA/MVA Vaccines for HIVR01AI071852 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2007 to 2009
$2.9M
PD-1 blockade as a therapy for SIV/AIDSR01AI074417 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2008 to 2010
$2.3M
PD-1 blockade combined with vaccination as a therapy for SIV/AIDSRC2CA149086 · NCI · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2009 to 2010
$999k
PD-1 blockade as a therapy for SIV/AIDSR56AI074417 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2011 to 2011
$854k
CYTOMETRIC CD4 COUNTING - A MINIMALIST APPROACHR43AI074471 · NIAID · HOWARD M. SHAPIRO, MD, P.C. · PI SHAPIRO, HOWARD M. · 2007 to 2007
$98k
NCI NIH HHS RC2 CA149086NCRR NIH HHS P51 RR000165NCRR NIH HHS P51 RR00165NIAID NIH HHS P01 AI088575NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI071852NIAID NIH HHS R01 AI074417NIAID NIH HHS R01 AI074471NIAID NIH HHS R37 AI112787NIAID NIH HHS R43 AI074471NIAID NIH HHS R56 AI074417NIAID NIH HHS U19 AI096187NIH HHS P51 OD011132
6 · The paper itself

Abstract

The inhibitory receptor programmed death-1 (PD-1) has been shown to regulate CD8 T cell function during chronic SIV infection; however, its role on CD4 T cells, specifically in the gut-associated lymphoid tissue, is less well understood. In this study, we show that a subset of CD4 T cells expresses high levels of PD-1 (PD-1(hi)) in the rectal mucosa, a preferential site of virus replication. The majority of these PD-1(hi) CD4 T cells expressed Bcl-6 and CXCR5, markers characteristic of T follicular helper cells in the lymph nodes. Following a pathogenic SIV infection, the frequency of PD-1(hi) cells (as a percentage of CD4 T cells) dramatically increased in the rectal mucosa; however, a significant fraction of them did not express CXCR5. Furthermore, only a small fraction of PD-1(hi) cells expressed CCR5, and despite this low level of viral coreceptor expression, a significant fraction of these cells were productively infected. Interestingly, vaccinated SIV controllers did not present with this aberrant PD-1(hi) CD4 T cell enrichment, and this lack of enrichment was associated with the presence of higher frequencies of SIV-specific granzyme B(+) CD8 T cells within the lymphoid tissue, suggesting a role for antiviral CD8 T cells in limiting aberrant expansion of PD-1(hi) CD4 T cells. These results highlight the importance of developing vaccines that enhance antiviral CD8 T cells at sites of preferential viral replication and support the need for developing therapeutic interventions that limit expansion of SIV(+)PD-1(hi) CD4 T cells at mucosal sites as a means to enhance viral control.

Indexed as

AnimalsAntigens, SurfaceCD4 Lymphocyte CountCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell SurvivalGene ExpressionImmunophenotypingInterleukin-2Intestinal MucosaLymph NodesMacaca mulattaPeyer's PatchesPhenotypeProgrammed Cell Death 1 ReceptorReceptors, CCR5Antigens, SurfaceInterleukin-2Programmed Cell Death 1 ReceptorReceptors, CCR5Receptors, CXCR5

Identifiers

PMID25246494
PMCPMC4201952
OpenAlexW1921684194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.